Table 4 Results of multiple linear regression models for inpatients suffering quota payment diseases and general diseases
Quota payment diseases | General diseases | |||
|---|---|---|---|---|
Crude model | Adjusted model | Crude model | Adjusted model | |
Total fee | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | −611.66 (−661.33, −561.99) *** | − 631.57 (− 681.15, − 581.99) *** | 2128.88 (1873.82, 2383.95) *** | 2094.25 (1837.18, 2351.33) *** |
 2016 | −810.46 (−858.37, −762.55) *** | − 827.06 (− 875.10, − 779.03) *** | 2686.53 (2418.57, 2954.50) *** | 2567.26 (2294.38, 2840.14) *** |
Actual compensation ratio | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | 20.02 (19.3, 20.74) *** | 20.26 (19.55, 20.98) *** | −8.29 (−8.66, −7.92) *** | − 8.57 (− 8.92, − 8.22) *** |
 2016 | 21.47 (20.77, 22.16) *** | 21.72 (21.03, 22.42) *** | −10.38 (−10.76, −9.99) *** | − 10.85 (− 11.22, − 10.47) *** |
Out-of-pocket ratio | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | −7.54 (− 7.73, − 7.36) *** | −7.47 (− 7.65, − 7.28) *** | 8.26 (7.89, 8.63) *** | 8.54 (8.19, 8.89) *** |
 2016 | −10.35 (− 10.53, − 10.17) *** | −10.21 (− 10.39, − 10.03) *** | 9.84 (9.45, 10.23) *** | 10.31 (9.93, 10.68) *** |
Constituent ratio of treatment fee | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | 3.48 (3.22, 3.74) *** | 3.62 (3.36, 3.87) *** | 4.81 (4.42, 5.19) *** | 4.90 (4.51, 5.28) *** |
 2016 | 9.33 (9.08, 9.58) *** | 9.45 (9.2, 9.70) *** | 9.74 (9.34, 10.15) *** | 10.06 (9.65, 10.47) *** |
Constituent ratio of inspection and laboratory fee | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | 0.23 (0.05, 0.41) *** | 0.18 (−0.01, 0.36) *** | 0.96 (0.71, 1.21) *** | 0.93 (0.68, 1.19) *** |
 2016 | 0.22 (0.04, 0.40) ** | 0.17 (−0.01, 0.35) * | 3.44 (3.17, 3.70) *** | 3.39 (3.12, 3.66) *** |
Length of stay | ||||
 2014 | 0 | 0 | 0 | 0 |
 2015 | −0.77 (−0.91, − 0.63) *** | −0.81 (− 0.95, − 0.67) *** | 1.16 (0.93, 1.39) *** | 0.93 (0.69, 1.16) *** |
 2016 | −1.21 (−1.34, −1.07) *** | −1.25 (−1.39, − 1.12) *** | 1.80 (1.55, 2.04) *** | 1.40 (1.16, 1.65) *** |